Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 217 entries
Sorted by: Best Match Show Resources per page
Apparatus for skidding sensitivity testing of energetic materials.

The Review of scientific instruments

Hewitt AT, Lee RJ, Watkins S, Brinkman J, Stephens JC, Dickens JC, Neuber AA.
PMID: 34243458
Rev Sci Instrum. 2021 Apr 01;92(4):045101. doi: 10.1063/5.0043825.

A remote-operated apparatus for testing the detonation sensitivity of energetic materials is detailed. Using an air ram and rotating disk, the normal force and transverse velocity of the impact plane are controlled independently, enabling the exploration of varying impact...

Cite
Hewitt AT, Lee RJ, Watkins S, et al. Apparatus for skidding sensitivity testing of energetic materials. Rev Sci Instrum. 2021;92(4):045101doi: 10.1063/5.0043825.
Hewitt, A. T., Lee, R. J., Watkins, S., Brinkman, J., Stephens, J. C., Dickens, J. C., & Neuber, A. A. (2021). Apparatus for skidding sensitivity testing of energetic materials. The Review of scientific instruments, 92(4), 045101. https://doi.org/10.1063/5.0043825
Hewitt, A T, et al. "Apparatus for skidding sensitivity testing of energetic materials." The Review of scientific instruments vol. 92,4 (2021): 045101. doi: https://doi.org/10.1063/5.0043825
Hewitt AT, Lee RJ, Watkins S, Brinkman J, Stephens JC, Dickens JC, Neuber AA. Apparatus for skidding sensitivity testing of energetic materials. Rev Sci Instrum. 2021 Apr 01;92(4):045101. doi: 10.1063/5.0043825. PMID: 34243458.
Copy Download .nbib Format: NLM
Phase interference for probing topological fractional charge in a BiSbTeSe.

Nanotechnology

Brevoord JM, Wielens DH, Lankhorst M, Díez-Mérida J, Huang Y, Li C, Brinkman A.
PMID: 34265751
Nanotechnology. 2021 Aug 02;32(43). doi: 10.1088/1361-6528/ac14e8.

Fractional charges can be induced by magnetic fluxes at the interface between a topological insulator (TI) and a type-II superconductor due to axion electrodynamics. In a Josephson junction array with a hole in the middle, these electronic states can...

Cite
Brevoord JM, Wielens DH, Lankhorst M, et al. Phase interference for probing topological fractional charge in a BiSbTeSe. Nanotechnology. 2021;32(43)doi: 10.1088/1361-6528/ac14e8.
Brevoord, J. M., Wielens, D. H., Lankhorst, M., Díez-Mérida, J., Huang, Y., Li, C., & Brinkman, A. (2021). Phase interference for probing topological fractional charge in a BiSbTeSe. Nanotechnology, 32(43), . https://doi.org/10.1088/1361-6528/ac14e8
Brevoord, J M, et al. "Phase interference for probing topological fractional charge in a BiSbTeSe." Nanotechnology vol. 32,43 (2021). doi: https://doi.org/10.1088/1361-6528/ac14e8
Brevoord JM, Wielens DH, Lankhorst M, Díez-Mérida J, Huang Y, Li C, Brinkman A. Phase interference for probing topological fractional charge in a BiSbTeSe. Nanotechnology. 2021 Aug 02;32(43). doi: 10.1088/1361-6528/ac14e8. PMID: 34265751.
Copy Download .nbib Format: NLM
Exhaled Metabolite Patterns to Identify Recent Asthma Exacerbations.

Metabolites

van Bragt JJMH, Principe S, Hashimoto S, Versteeg DN, Brinkman P, Vijverberg SJH, Weersink EJM, Scichilone N, Maitland-van der Zee AH.
PMID: 34940630
Metabolites. 2021 Dec 15;11(12). doi: 10.3390/metabo11120872.

Asthma is a chronic respiratory disease that can lead to exacerbations, defined as acute episodes of worsening respiratory symptoms and lung function. Predicting the occurrence of these exacerbations is an important goal in asthma management. The measurement of exhaled...

Cite
van Bragt JJMH, Principe S, Hashimoto S, et al. Exhaled Metabolite Patterns to Identify Recent Asthma Exacerbations. Metabolites. 2021;11(12)doi: 10.3390/metabo11120872.
van Bragt, J. J. M. H., Principe, S., Hashimoto, S., Versteeg, D. N., Brinkman, P., Vijverberg, S. J. H., Weersink, E. J. M., Scichilone, N., & Maitland-van der Zee, A. H. (2021). Exhaled Metabolite Patterns to Identify Recent Asthma Exacerbations. Metabolites, 11(12), . https://doi.org/10.3390/metabo11120872
van Bragt, Job J M H, et al. "Exhaled Metabolite Patterns to Identify Recent Asthma Exacerbations." Metabolites vol. 11,12 (2021). doi: https://doi.org/10.3390/metabo11120872
van Bragt JJMH, Principe S, Hashimoto S, Versteeg DN, Brinkman P, Vijverberg SJH, Weersink EJM, Scichilone N, Maitland-van der Zee AH. Exhaled Metabolite Patterns to Identify Recent Asthma Exacerbations. Metabolites. 2021 Dec 15;11(12). doi: 10.3390/metabo11120872. PMID: 34940630.
Copy Download .nbib Format: NLM
Comparison of outcome and characteristics between 6343 COVID-19 patients and 2256 other community-acquired viral pneumonia patients admitted to Dutch ICUs.

Journal of critical care

Brinkman S, Termorshuizen F, Dongelmans DA, Bakhshi-Raiez F, Arbous MS, de Lange DW, de Keizer NF.
PMID: 34929530
J Crit Care. 2021 Dec 17;68:76-82. doi: 10.1016/j.jcrc.2021.12.007. Epub 2021 Dec 17.

PURPOSE: Describe the differences in characteristics and outcomes between COVID-19 and other viral pneumonia patients admitted to Dutch ICUs.MATERIALS AND METHODS: Data from the National-Intensive-Care-Evaluation-registry of COVID-19 patients admitted between February 15th and January 1th 2021 and other viral...

Cite
Brinkman S, Termorshuizen F, Dongelmans DA, et al. Comparison of outcome and characteristics between 6343 COVID-19 patients and 2256 other community-acquired viral pneumonia patients admitted to Dutch ICUs. J Crit Care. 2021;68:76-82doi: 10.1016/j.jcrc.2021.12.007.
Brinkman, S., Termorshuizen, F., Dongelmans, D. A., Bakhshi-Raiez, F., Arbous, M. S., de Lange, D. W., de Keizer, N. F. (2021). Comparison of outcome and characteristics between 6343 COVID-19 patients and 2256 other community-acquired viral pneumonia patients admitted to Dutch ICUs. Journal of critical care, 6876-82. https://doi.org/10.1016/j.jcrc.2021.12.007
Brinkman, S, et al. "Comparison of outcome and characteristics between 6343 COVID-19 patients and 2256 other community-acquired viral pneumonia patients admitted to Dutch ICUs." Journal of critical care vol. 68 (2021): 76-82. doi: https://doi.org/10.1016/j.jcrc.2021.12.007
Brinkman S, Termorshuizen F, Dongelmans DA, Bakhshi-Raiez F, Arbous MS, de Lange DW, de Keizer NF. Comparison of outcome and characteristics between 6343 COVID-19 patients and 2256 other community-acquired viral pneumonia patients admitted to Dutch ICUs. J Crit Care. 2021 Dec 17;68:76-82. doi: 10.1016/j.jcrc.2021.12.007. Epub 2021 Dec 17. PMID: 34929530; PMCID: PMC8683137.
Copy Download .nbib Format: NLM
External tuning of topological phase transitions induced by interaction driven mass renormalization.

Journal of physics. Condensed matter : an Institute of Physics journal

Jansen T, Brinkman A.
PMID: 34753111
J Phys Condens Matter. 2021 Nov 23;34(7). doi: 10.1088/1361-648X/ac37d9.

Electron-electron interactions can be useful for realizing new nontrivial topological phases of matter. Here, we show by means of a tight-binding model and mean field theory how electron-electron interactions can lead to a topological phase transition. By externally adding...

Cite
Jansen T, Brinkman A. External tuning of topological phase transitions induced by interaction driven mass renormalization. J Phys Condens Matter. 2021;34(7)doi: 10.1088/1361-648X/ac37d9.
Jansen, T., & Brinkman, A. (2021). External tuning of topological phase transitions induced by interaction driven mass renormalization. Journal of physics. Condensed matter : an Institute of Physics journal, 34(7), . https://doi.org/10.1088/1361-648X/ac37d9
Jansen, Thies, and Brinkman, Alexander. "External tuning of topological phase transitions induced by interaction driven mass renormalization." Journal of physics. Condensed matter : an Institute of Physics journal vol. 34,7 (2021). doi: https://doi.org/10.1088/1361-648X/ac37d9
Jansen T, Brinkman A. External tuning of topological phase transitions induced by interaction driven mass renormalization. J Phys Condens Matter. 2021 Nov 23;34(7). doi: 10.1088/1361-648X/ac37d9. PMID: 34753111.
Copy Download .nbib Format: NLM
Body Mass Index and Mortality in Coronavirus Disease 2019 and Other Diseases: A Cohort Study in 35,506 ICU Patients.

Critical care medicine

Kooistra EJ, Brinkman S, van der Voort PHJ, de Keizer NF, Dongelmans DA, Kox M, Pickkers P.
PMID: 34374504
Crit Care Med. 2022 Jan 01;50(1):e1-e10. doi: 10.1097/CCM.0000000000005216.

OBJECTIVES: Obesity is a risk factor for severe coronavirus disease 2019 and might play a role in its pathophysiology. It is unknown whether body mass index is related to clinical outcome following ICU admission, as observed in various other...

Cite
Kooistra EJ, Brinkman S, van der Voort PHJ, et al. Body Mass Index and Mortality in Coronavirus Disease 2019 and Other Diseases: A Cohort Study in 35,506 ICU Patients. Crit Care Med. 2022;50(1):e1-e10doi: 10.1097/CCM.0000000000005216.
Kooistra, E. J., Brinkman, S., van der Voort, P. H. J., de Keizer, N. F., Dongelmans, D. A., Kox, M., & Pickkers, P. (2022). Body Mass Index and Mortality in Coronavirus Disease 2019 and Other Diseases: A Cohort Study in 35,506 ICU Patients. Critical care medicine, 50(1), e1-e10. https://doi.org/10.1097/CCM.0000000000005216
Kooistra, Emma J, et al. "Body Mass Index and Mortality in Coronavirus Disease 2019 and Other Diseases: A Cohort Study in 35,506 ICU Patients." Critical care medicine vol. 50,1 (2022): e1-e10. doi: https://doi.org/10.1097/CCM.0000000000005216
Kooistra EJ, Brinkman S, van der Voort PHJ, de Keizer NF, Dongelmans DA, Kox M, Pickkers P. Body Mass Index and Mortality in Coronavirus Disease 2019 and Other Diseases: A Cohort Study in 35,506 ICU Patients. Crit Care Med. 2022 Jan 01;50(1):e1-e10. doi: 10.1097/CCM.0000000000005216. PMID: 34374504; PMCID: PMC8670082.
Copy Download .nbib Format: NLM
Lumacaftor/ivacaftor changes the lung microbiome and metabolome in cystic fibrosis patients.

ERJ open research

Neerincx AH, Whiteson K, Phan JL, Brinkman P, Abdel-Aziz MI, Weersink EJM, Altenburg J, Majoor CJ, Maitland-van der Zee AH, Bos LDJ.
PMID: 33898610
ERJ Open Res. 2021 Apr 19;7(2). doi: 10.1183/23120541.00731-2020. eCollection 2021 Apr.

RATIONALE: Targeted cystic fibrosis (CF) therapy with lumacaftor/ivacaftor partly restores chloride channel function and improves epithelial fluid transport in the airways. Consequently, changes may occur in the microbiome, which is adapted to CF lungs.OBJECTIVES: To investigate the effects of...

Cite
Neerincx AH, Whiteson K, Phan JL, et al. Lumacaftor/ivacaftor changes the lung microbiome and metabolome in cystic fibrosis patients. ERJ Open Res. 2021;7(2)doi: 10.1183/23120541.00731-2020.
Neerincx, A. H., Whiteson, K., Phan, J. L., Brinkman, P., Abdel-Aziz, M. I., Weersink, E. J. M., Altenburg, J., Majoor, C. J., Maitland-van der Zee, A. H., & Bos, L. D. J. (2021). Lumacaftor/ivacaftor changes the lung microbiome and metabolome in cystic fibrosis patients. ERJ open research, 7(2), . https://doi.org/10.1183/23120541.00731-2020
Neerincx, Anne H, et al. "Lumacaftor/ivacaftor changes the lung microbiome and metabolome in cystic fibrosis patients." ERJ open research vol. 7,2 (2021). doi: https://doi.org/10.1183/23120541.00731-2020
Neerincx AH, Whiteson K, Phan JL, Brinkman P, Abdel-Aziz MI, Weersink EJM, Altenburg J, Majoor CJ, Maitland-van der Zee AH, Bos LDJ. Lumacaftor/ivacaftor changes the lung microbiome and metabolome in cystic fibrosis patients. ERJ Open Res. 2021 Apr 19;7(2). doi: 10.1183/23120541.00731-2020. eCollection 2021 Apr. PMID: 33898610; PMCID: PMC8053817.
Copy Download .nbib Format: NLM
Targeting the endocannabinoid system with microbial interventions to improve gut integrity.

Progress in neuro-psychopharmacology & biological psychiatry

Jansma J, Brinkman F, van Hemert S, El Aidy S.
PMID: 33186639
Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 02;106:110169. doi: 10.1016/j.pnpbp.2020.110169. Epub 2020 Nov 11.

The endocannabinoid system is a metabolic pathway involved in the communication between the gut microbiota and the host. In the gut, the endocannabinoid system regulates the integrity of the intestinal barrier. A compromised integrity of the intestinal barrier is...

Cite
Jansma J, Brinkman F, van Hemert S, et al. Targeting the endocannabinoid system with microbial interventions to improve gut integrity. Prog Neuropsychopharmacol Biol Psychiatry. 2020;106:110169doi: 10.1016/j.pnpbp.2020.110169.
Jansma, J., Brinkman, F., van Hemert, S., & El Aidy, S. (2021). Targeting the endocannabinoid system with microbial interventions to improve gut integrity. Progress in neuro-psychopharmacology & biological psychiatry, 106110169. https://doi.org/10.1016/j.pnpbp.2020.110169
Jansma, Jack, et al. "Targeting the endocannabinoid system with microbial interventions to improve gut integrity." Progress in neuro-psychopharmacology & biological psychiatry vol. 106 (2021): 110169. doi: https://doi.org/10.1016/j.pnpbp.2020.110169
Jansma J, Brinkman F, van Hemert S, El Aidy S. Targeting the endocannabinoid system with microbial interventions to improve gut integrity. Prog Neuropsychopharmacol Biol Psychiatry. 2021 Mar 02;106:110169. doi: 10.1016/j.pnpbp.2020.110169. Epub 2020 Nov 11. PMID: 33186639.
Copy Download .nbib Format: NLM
Characteristics and outcome of COVID-19 patients admitted to the ICU: a nationwide cohort study on the comparison between the first and the consecutive upsurges of the second wave of the COVID-19 pandemic in the Netherlands.

Annals of intensive care

Dongelmans DA, Termorshuizen F, Brinkman S, Bakhshi-Raiez F, Arbous MS, de Lange DW, van Bussel BCT, de Keizer NF.
PMID: 35024981
Ann Intensive Care. 2022 Jan 13;12(1):5. doi: 10.1186/s13613-021-00978-3.

BACKGROUND: To assess trends in the quality of care for COVID-19 patients at the ICU over the course of time in the Netherlands.METHODS: Data from the National Intensive Care Evaluation (NICE)-registry of all COVID-19 patients admitted to an ICU...

Cite
Dongelmans DA, Termorshuizen F, Brinkman S, et al. Characteristics and outcome of COVID-19 patients admitted to the ICU: a nationwide cohort study on the comparison between the first and the consecutive upsurges of the second wave of the COVID-19 pandemic in the Netherlands. Ann Intensive Care. 2022;12(1):5doi: 10.1186/s13613-021-00978-3.
Dongelmans, D. A., Termorshuizen, F., Brinkman, S., Bakhshi-Raiez, F., Arbous, M. S., de Lange, D. W., van Bussel, B. C. T., de Keizer, N. F. (2022). Characteristics and outcome of COVID-19 patients admitted to the ICU: a nationwide cohort study on the comparison between the first and the consecutive upsurges of the second wave of the COVID-19 pandemic in the Netherlands. Annals of intensive care, 12(1), 5. https://doi.org/10.1186/s13613-021-00978-3
Dongelmans, Dave A, et al. "Characteristics and outcome of COVID-19 patients admitted to the ICU: a nationwide cohort study on the comparison between the first and the consecutive upsurges of the second wave of the COVID-19 pandemic in the Netherlands." Annals of intensive care vol. 12,1 (2022): 5. doi: https://doi.org/10.1186/s13613-021-00978-3
Dongelmans DA, Termorshuizen F, Brinkman S, Bakhshi-Raiez F, Arbous MS, de Lange DW, van Bussel BCT, de Keizer NF. Characteristics and outcome of COVID-19 patients admitted to the ICU: a nationwide cohort study on the comparison between the first and the consecutive upsurges of the second wave of the COVID-19 pandemic in the Netherlands. Ann Intensive Care. 2022 Jan 13;12(1):5. doi: 10.1186/s13613-021-00978-3. PMID: 35024981; PMCID: PMC8755895.
Copy Download .nbib Format: NLM
Immune reconstitution inflammatory syndrome in HIV infected late presenters starting integrase inhibitor containing antiretroviral therapy.

EClinicalMedicine

Wijting IEA, Wit FWNM, Rokx C, Leyten EMS, Lowe SH, Brinkman K, Bierman WFW, van Kasteren MEE, Postma AM, Bloemen VCM, Bouchtoubi G, Hoepelman AIM, van der Ende ME, Reiss P, Rijnders BJA.
PMID: 31891143
EClinicalMedicine. 2019 Dec 13;17:100210. doi: 10.1016/j.eclinm.2019.11.003. eCollection 2019 Dec.

BACKGROUND: Integrase inhibitors (INI) induce a rapid decline of HIV-RNA in plasma and CD4METHODS: Study within the Dutch ATHENA HIV observational cohort. HIV-1 infected late presenters initiating cART after March 2009 were included if they had

Cite
Wijting IEA, Wit FWNM, Rokx C, et al. Immune reconstitution inflammatory syndrome in HIV infected late presenters starting integrase inhibitor containing antiretroviral therapy. EClinicalMedicine. 2019;17:100210doi: 10.1016/j.eclinm.2019.11.003.
Wijting, I. E. A., Wit, F. W. N. M., Rokx, C., Leyten, E. M. S., Lowe, S. H., Brinkman, K., Bierman, W. F. W., van Kasteren, M. E. E., Postma, A. M., Bloemen, V. C. M., Bouchtoubi, G., Hoepelman, A. I. M., van der Ende, M. E., Reiss, P., Rijnders, B. J. A. (2019). Immune reconstitution inflammatory syndrome in HIV infected late presenters starting integrase inhibitor containing antiretroviral therapy. EClinicalMedicine, 17100210. https://doi.org/10.1016/j.eclinm.2019.11.003
Wijting, Ingeborg E A, et al. "Immune reconstitution inflammatory syndrome in HIV infected late presenters starting integrase inhibitor containing antiretroviral therapy." EClinicalMedicine vol. 17 (2019): 100210. doi: https://doi.org/10.1016/j.eclinm.2019.11.003
Wijting IEA, Wit FWNM, Rokx C, Leyten EMS, Lowe SH, Brinkman K, Bierman WFW, van Kasteren MEE, Postma AM, Bloemen VCM, Bouchtoubi G, Hoepelman AIM, van der Ende ME, Reiss P, Rijnders BJA. Immune reconstitution inflammatory syndrome in HIV infected late presenters starting integrase inhibitor containing antiretroviral therapy. EClinicalMedicine. 2019 Dec 13;17:100210. doi: 10.1016/j.eclinm.2019.11.003. eCollection 2019 Dec. PMID: 31891143; PMCID: PMC6933261.
Copy Download .nbib Format: NLM
Lasting Symptoms After Esophageal Resection (LASER): European Multicenter Cross-sectional Study.

Annals of surgery

Markar SR, Zaninotto G, Castoro C, Johar A, Lagergren P, Elliott JA, Gisbertz SS, Mariette C, Alfieri R, Huddy J, Sounderajah V, Pinto E, Scarpa M, Klevebro F, Sunde B, Murphy CF, Greene C, Ravi N, Piessen G, Brenkman H, Ruurda JP, Van Hillegersberg R, Lagarde S, Wijnhoven B, Pera M, Roig J, Castro S, Matthijsen R, Findlay J, Antonowicz S, Maynard N, McCormack O, Ariyarathenam A, Sanders G, Cheong E, Jaunoo S, Allum W, Van Lanschot J, Nilsson M, Reynolds JV, van Berge Henegouwen MI, Hanna GB.
PMID: 32404661
Ann Surg. 2020 Nov 17; doi: 10.1097/SLA.0000000000003917. Epub 2020 Nov 17.

OBJECTIVE: To identify the most prevalent symptoms and those with greatest impact upon health-related quality of life (HRQOL) among esophageal cancer survivors.BACKGROUND: Long-term symptom burden after esophagectomy, and associations with HRQOL, are poorly understood.PATIENTS AND METHODS: Between 2010 and...

Cite
Markar SR, Zaninotto G, Castoro C, et al. Lasting Symptoms After Esophageal Resection (LASER): European Multicenter Cross-sectional Study. Ann Surg. 2020;doi: 10.1097/SLA.0000000000003917.
Markar, S. R., Zaninotto, G., Castoro, C., Johar, A., Lagergren, P., Elliott, J. A., Gisbertz, S. S., Mariette, C., Alfieri, R., Huddy, J., Sounderajah, V., Pinto, E., Scarpa, M., Klevebro, F., Sunde, B., Murphy, C. F., Greene, C., Ravi, N., Piessen, G., Brenkman, H., Ruurda, J. P., Van Hillegersberg, R., Lagarde, S., Wijnhoven, B., Pera, M., Roig, J., Castro, S., Matthijsen, R., Findlay, J., Antonowicz, S., Maynard, N., McCormack, O., Ariyarathenam, A., Sanders, G., Cheong, E., Jaunoo, S., Allum, W., Van Lanschot, J., Nilsson, M., Reynolds, J. V., van Berge Henegouwen, M. I., & Hanna, G. B. (2020). Lasting Symptoms After Esophageal Resection (LASER): European Multicenter Cross-sectional Study. Annals of surgery, . https://doi.org/10.1097/SLA.0000000000003917
Markar, Sheraz R, et al. "Lasting Symptoms After Esophageal Resection (LASER): European Multicenter Cross-sectional Study." Annals of surgery vol. (2020). doi: https://doi.org/10.1097/SLA.0000000000003917
Markar SR, Zaninotto G, Castoro C, Johar A, Lagergren P, Elliott JA, Gisbertz SS, Mariette C, Alfieri R, Huddy J, Sounderajah V, Pinto E, Scarpa M, Klevebro F, Sunde B, Murphy CF, Greene C, Ravi N, Piessen G, Brenkman H, Ruurda JP, Van Hillegersberg R, Lagarde S, Wijnhoven B, Pera M, Roig J, Castro S, Matthijsen R, Findlay J, Antonowicz S, Maynard N, McCormack O, Ariyarathenam A, Sanders G, Cheong E, Jaunoo S, Allum W, Van Lanschot J, Nilsson M, Reynolds JV, van Berge Henegouwen MI, Hanna GB. Lasting Symptoms After Esophageal Resection (LASER): European Multicenter Cross-sectional Study. Ann Surg. 2020 Nov 17; doi: 10.1097/SLA.0000000000003917. Epub 2020 Nov 17. PMID: 32404661.
Copy Download .nbib Format: NLM
Exhaled Metabolite Patterns to Identify Recent Asthma Exacerbations.

Metabolites

van Bragt JJMH, Principe S, Hashimoto S, Versteeg DN, Brinkman P, Vijverberg SJH, Weersink EJM, Scichilone N, Maitland-van der Zee AH.
PMID: 34940630
Metabolites. 2021 Dec 15;11(12). doi: 10.3390/metabo11120872.

Asthma is a chronic respiratory disease that can lead to exacerbations, defined as acute episodes of worsening respiratory symptoms and lung function. Predicting the occurrence of these exacerbations is an important goal in asthma management. The measurement of exhaled...

Cite
van Bragt JJMH, Principe S, Hashimoto S, et al. Exhaled Metabolite Patterns to Identify Recent Asthma Exacerbations. Metabolites. 2021;11(12)doi: 10.3390/metabo11120872.
van Bragt, J. J. M. H., Principe, S., Hashimoto, S., Versteeg, D. N., Brinkman, P., Vijverberg, S. J. H., Weersink, E. J. M., Scichilone, N., & Maitland-van der Zee, A. H. (2021). Exhaled Metabolite Patterns to Identify Recent Asthma Exacerbations. Metabolites, 11(12), . https://doi.org/10.3390/metabo11120872
van Bragt, Job J M H, et al. "Exhaled Metabolite Patterns to Identify Recent Asthma Exacerbations." Metabolites vol. 11,12 (2021). doi: https://doi.org/10.3390/metabo11120872
van Bragt JJMH, Principe S, Hashimoto S, Versteeg DN, Brinkman P, Vijverberg SJH, Weersink EJM, Scichilone N, Maitland-van der Zee AH. Exhaled Metabolite Patterns to Identify Recent Asthma Exacerbations. Metabolites. 2021 Dec 15;11(12). doi: 10.3390/metabo11120872. PMID: 34940630.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 217 entries